White label – Pompe disease - ClinicalTrials.eu

A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Recruiting

2 1

+1
A study of navenibart for long-term safety in patients with hereditary angioedema

Recruiting

3 1
Investigated Diseases:
- Hereditary angioedema
- Hereditary angioedema with C1 esterase inhibitor deficiency
Investigated Drugs:
- NAVENIBART
+5
A Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial

Recruiting

2 1 1
Investigated Drugs:
- PF-07868489
+1
Study of ONC206 for children and young adults with newly diagnosed or recurrent diffuse midline glioma and other recurrent brain tumors

Recruiting

1 1 1
Investigated Diseases:
A Study of Olpasiran for Patients With Stable Heart and Blood Vessel Disease and High Lipoprotein(a) to Measure Changes in Artery Plaque Using Heart Scans

Recruiting

3 1
A study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors

Recruiting

4 1 1 1
Investigated Diseases:
- Pancreatic neuroendocrine tumour
Investigated Drugs:
- N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
- Everolimus
+2
A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Recruiting

3 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Duvakitug
+9
A study testing how inebilizumab works and how safe it is in children and teenagers aged 2 to 17 years with generalized myasthenia gravis

Recruiting

2 1 1 1
Investigated Diseases:
- Myasthenia gravis
Investigated Drugs:
- Inebilizumab
A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Recruiting

3 1
Investigated Drugs:
- Duvakitug
+9
Study of abatacept, tocilizumab, and tofacitinib compared to a second TNF inhibitor for children with juvenile idiopathic arthritis who did not respond to TNF inhibitor treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Juvenile idiopathic arthritis
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies